Quick Links
About MyHaemophiliaTeam
Powered By
Below is a listing of treatments and therapies for haemophilia. Click on one to read more information or connect with others currently using it.
Overview
Advate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Advate can also be used for… read more
Overview
Adynovate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in adults and adolescents over the age of 12 with factor VIII deficiency due to hemophilia A. Adynovate… read more
Overview
Afstyla is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Afstyla can also be used for… read more
Overview
Alhemo is approved by the U.S. Food and Drug Administration (FDA) for the routine prophylaxis (prevention) of bleeding episodes in adults and children aged 12 years and older with hemophilia A (congenital factor…
Overview
Alphanate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Alphanate is also used in people… read more
Overview
AlphaNine SD is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of AlphaNine SD is Coagulation factor IX factor (human).… read more
Overview
Alprolix is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Alprolix can also be used for perioperative (before, during, and… read more
Overview
Altuviiio is approved by the U.S. Food and Drug Administration (FDA) for use in adults and children with hemophilia A (congenital factor VIII deficiency). It is indicated for routine prophylaxis to reduce…
Overview
Amicar is approved by the Food and Drug Administration (FDA) to stop bleeding. Amicar may be used during heart surgery and for bleeding disorders such as hemophilia. Amicar is also known by its drug name,… read more
Overview
Bebulin is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Bebulin is Factor IX complex (human).
Bebulin is a clotting… read more
Overview
BeneFix is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. BeneFix can also be used for perioperative (before, during, and… read more
Overview
People with hemophilia who have developed inhibitors may need frequent or urgent doses of intravenous medications, especially while undergoing immune tolerance therapy. Some people choose to have a central… read more
Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for hemophilia. Eligibility may be based on specifics of your condition, such as which clotting factor… read more
Overview
Coagadex is approved by the U.S. Food and Drug Administration (FDA) for use in adults and children with hereditary factor X (10) deficiency. It is indicated for routine prophylaxis to reduce bleeding episodes…
Overview
Corifact is approved by the Food and Drug Administration (FDA) for routine prophylaxis and perioperative (before, during, and after surgery) care in children and adults with congenital factor XIII deficiency.… read more
Overview
Cyklokapron is approved by the Food and Drug Administration (FDA) for short-term use in people with hemophilia. Cyklokapron may be used for two to eight days to reduce or prevent hemorrhage during and after… read more
Overview
DDAVP is approved by the U.S. Food and Drug Administration (FDA) for use in people with hemophilia A who have factor VIII (8) coagulant activity levels greater than 5 percent as well as for people with von…
Overview
Eloctate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Eloctate can also be used for… read more
Overview
Esperoct is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in adults and children with factor VIII deficiency due to hemophilia A. Esperoct can also be used for… read more
Overview
Exercise can strengthen your muscles, help protect your joints, and lower your risk for bleeds. Exercise can improve your flexibility and decrease stiffness. Better fitness can help improve balance and cut down… read more
Overview
Feiba is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in people with hemophilia A and B who have developed inhibitors. Feiba can also be used for perioperative (before,… read more
Overview
Helixate FS is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Helixate FS can also be used for perioperative (before,… read more
Overview
Hemgenix is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with hemophilia B. To be eligible for Hemgenix, you must either currently be using factor IX (9)… read more
Overview
Hemlibra is approved by the Food and Drug Administration (FDA) as routine prophylaxis in children and adults with hemophilia A and factor VIII inhibitors. The technical name of Hemlibra is Emicizumab-kxwh.… read more
Overview
Hemofil M is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in people with factor VIII deficiency due to hemophilia A. The technical name of Hemofil M is… read more
Overview
It is strongly recommended that everyone with a bleeding disorder such as hemophilia receive vaccinations for Hepatitis A and Hepatitis B.
What does it involve?
Both Hepatitis A and Hepatitis B… read more
Overview
Humate-P is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Humate-P is also used to treat bleeding episodes and for perioperative (before,… read more
Overview
Hympavzi is approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and children 12 and up with hemophilia A (congenital…
Overview
Idelvion is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor IX deficiency due to hemophilia B. Idelvion can also be used for… read more
Overview
Immune tolerance therapy (ITT) involves infusing clotting factor concentrate in scheduled doses to train the body to tolerate the factor. The goal of ITT is to eradicate the inhibitor.
What does it involve?… read more
Overview
Ixinity is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults and children age 12 or older with hemophilia B. Ixinity can also be used for perioperative (before,… read more
Overview
Jivi is a recombinant antihemophilic factor approved by the U.S. Food and Drug Administration (FDA) for the treatment and management of hemophilia A (congenital factor VIII [8] deficiency) in previously treated…
Overview
Joint bleeds carry the risks of pain, long-term damage, and even disability. Wrapping a bleeding joint reduces blood flow using compression and possibly cold.
What does it involve?
There are many… read more
Overview
Koate-DVI is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Koate-DVI can also be used for perioperative (before, during, and after surgery)… read more
The Kogenate FS brand name has been discontinued in the U.S. Generic alternatives may be available.
Overview
Kogenate FS is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in…
read moreOverview
Konyne 80 is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. Konyne 80 may also be used to reverse coumarin anticoagulant-induced hemorrhage and… read more
Overview
Kovaltry is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Kovaltry can also be used for… read more
Overview Monoclate P is approved by the Food and Drug Administration (FDA) to control bleeding episodes and for perioperative (before, during, and after surgery) care in adults and children with factor VIII deficiency…
read moreOverview
Mononine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Mononine is Coagulation factor IX factor (human).
Mononine… read more
Overview
Novoeight is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Novoeight can also be used for perioperative (before, during,… read more
Overview
NovoSeven RT is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A or B. Typically, NovoSeven RT… read more
Overview
Nuwiq is approved by the Food and Drug Administration (FDA) to treat and prevent bleeding episodes in children and adults with hemophilia A (congenital factor VIII deficiency). The technical name of Nuwiq is… read more
Overview
Obizur is approved by the Food and Drug Administration (FDA) to control bleeding episodes in adults with acquired hemophilia. The technical name of Obizur is Antihemophilic factor (recombinant), porcine… read more
Overview
Physical therapy can help keep your joints and muscles working properly. Physical therapy can also rehabilitate joints after a bleed. Better fitness can help improve balance and strength and cut down on… read more
Overview
Profilnine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Profilnine is Factor IX complex (human).
Profilnine is a… read more
Overview
Proplex-T is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. Proplex-T may also be used for perioperative (before, during, and after surgery)… read more
Overview
Qfitlia is a medication used to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with hemophilia A or B, with or without inhibitors to factor VIII or IX. It is approved by…
read moreOverview Rebinyn is approved by the Food and Drug Administration (FDA) to treat bleeding episodes in adults and children with hemophilia B. Rebinyn can also be used for perioperative (before, during, and after surgery)…
read moreOverview
Recombinate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Recombinate can also be used for perioperative (before,… read more
Overview
ReFacto is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. ReFacto can also be used for perioperative (before, during, and… read more
Overview
RiaSTAP is approved by the Food and Drug Administration (FDA) to treat acute bleeding episodes in people with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. The technical… read more
Overview
Rixubis is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Rixubis can also be used for perioperative (before, during, and… read more
Overview
Roctavian is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with severe hemophilia A. Roctavian is also known by its drug name, valoctocogene… read more
Overview
Sevenfact is approved by the U.S. Food and Drug Administration (FDA) for the treatment and control of bleeding episodes in adults and adolescents (12 years and older) who have hemophilia A or B with inhibitors…
The Stimate brand name has been discontinued in the U.S. Generic alternatives may be available.
The Stimate brand name has been discontinued in the U.S. Generic alternatives may be available.
Overview
Stimate is approved by…
read moreOverview Tretten is approved by the Food and Drug Administration (FDA) for routine prophylaxis in children and adults with congenital factor XIII A-subunit deficiency. The technical name of Tretten is Coagulation factor…
read moreOverview
Vonvendi is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in adults with von Willebrand disease. The technical name of Vonvendi is von Willebrand… read more
Overview
Wilate is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in children and adults with von Willebrand disease. Wilate can also be used for… read more
Overview
Xyntha is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Xyntha can also be used for perioperative (before, during, and… read more
Sign up for free!
Continue with Facebook
Sign up with your email
Your privacy is our priority.
Join